DE69916326D1 - Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom - Google Patents

Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom

Info

Publication number
DE69916326D1
DE69916326D1 DE69916326T DE69916326T DE69916326D1 DE 69916326 D1 DE69916326 D1 DE 69916326D1 DE 69916326 T DE69916326 T DE 69916326T DE 69916326 T DE69916326 T DE 69916326T DE 69916326 D1 DE69916326 D1 DE 69916326D1
Authority
DE
Germany
Prior art keywords
multiple myeloma
treating bone
bone damage
medical compositions
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69916326T
Other languages
English (en)
Other versions
DE69916326T2 (de
Inventor
Shohei Tanaka
Hironobu Asano
Utane Matsukawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of DE69916326D1 publication Critical patent/DE69916326D1/de
Application granted granted Critical
Publication of DE69916326T2 publication Critical patent/DE69916326T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69916326T 1998-12-25 1999-12-22 Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom Expired - Fee Related DE69916326T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP36869998 1998-12-25
JP36869998 1998-12-25
PCT/JP1999/007236 WO2000038694A1 (fr) 1998-12-25 1999-12-22 Compositions de medicaments servant a traiter les lesions osseuses dans le myelome multiple

Publications (2)

Publication Number Publication Date
DE69916326D1 true DE69916326D1 (de) 2004-05-13
DE69916326T2 DE69916326T2 (de) 2005-03-17

Family

ID=18492511

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916326T Expired - Fee Related DE69916326T2 (de) 1998-12-25 1999-12-22 Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom

Country Status (12)

Country Link
US (2) US6727233B1 (de)
EP (1) EP1147773B1 (de)
JP (1) JP3219402B2 (de)
KR (1) KR100609256B1 (de)
CN (1) CN1151793C (de)
AT (1) ATE263566T1 (de)
AU (1) AU1798700A (de)
CA (1) CA2356294C (de)
DE (1) DE69916326T2 (de)
ES (1) ES2220133T3 (de)
TW (1) TW476649B (de)
WO (1) WO2000038694A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4692283B2 (ja) * 2003-12-12 2011-06-01 アステラス製薬株式会社 悪性黒色腫治療剤
US20070191311A1 (en) * 2004-01-30 2007-08-16 Shuichiro Kakimoto P2x receptor inhibitor
WO2005072747A1 (ja) * 2004-02-02 2005-08-11 Ono Pharmaceutical Co., Ltd. 骨吸収抑制剤
US7403028B2 (en) * 2006-06-12 2008-07-22 Cascade Microtech, Inc. Test structure and probe for differential signals
JP2018131403A (ja) * 2017-02-15 2018-08-23 大蔵製薬株式会社 ミノドロン酸の含水医薬製剤
US20230293649A1 (en) * 2020-07-31 2023-09-21 Bioventures, Llc Cst6, cells expressing cst6 and methods of use
CN115040524A (zh) * 2022-07-27 2022-09-13 深圳市中西医结合医院 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0699457B2 (ja) * 1988-08-12 1994-12-07 山之内製薬株式会社 ヘテロ環ビスフォスフォン酸誘導体およびその医薬
US4990503A (en) 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
DK0647649T3 (da) * 1992-06-23 1999-07-26 Yamanouchi Pharma Co Ltd Ny krystal af heterocyklisk bis(phosphonsyre)monohydratderivat
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
IL133535A0 (en) * 1997-07-22 2001-04-30 Merck & Co Inc Method for inhibiting bone resorption

Also Published As

Publication number Publication date
EP1147773B1 (de) 2004-04-07
CN1331598A (zh) 2002-01-16
US20040043966A1 (en) 2004-03-04
KR100609256B1 (ko) 2006-08-04
DE69916326T2 (de) 2005-03-17
US6987100B2 (en) 2006-01-17
EP1147773A4 (de) 2002-07-03
CN1151793C (zh) 2004-06-02
CA2356294C (en) 2007-06-05
EP1147773A1 (de) 2001-10-24
ATE263566T1 (de) 2004-04-15
US6727233B1 (en) 2004-04-27
JP3219402B2 (ja) 2001-10-15
TW476649B (en) 2002-02-21
CA2356294A1 (en) 2000-07-06
AU1798700A (en) 2000-07-31
WO2000038694A1 (fr) 2000-07-06
KR20010092751A (ko) 2001-10-26
ES2220133T3 (es) 2004-12-01

Similar Documents

Publication Publication Date Title
SE9901272D0 (sv) New improved formulation
WO2002074234A3 (en) Method and composition for treatment of skeletal dysplasias
EP1275396A3 (de) Verwendung von Angiotensin II Fragmenten und deren Analogen fÜr Gewebewiederherstellung
DE69331326D1 (de) Prostaglandin-analoga zur behandlung von osteoporose
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
AP9901478A0 (en) Compounds for the treatment of ischemia.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DK0677289T3 (da) Farmaceutisk præparat til behandling af osteoporose
ATE162073T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol
DE69916326D1 (de) Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ATE329619T1 (de) Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
WO2000038660A3 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
BR9912341A (pt) Composição antimicrobiana e processo para inibir o crescimento microbiano em um sistema aquoso e em um artigo de fabricação
ATE152879T1 (de) Antiparasitäre zusammensetzung zur verwendung bei tieren
ATE287724T1 (de) Verfahren zur vorbeugung und behandlung von beschädigung des schleimhautgewebes
AR029394A1 (es) Arilcetonas substituidas, procedimientos para su preparacion, benzoilcetonas utiles en dicho procedimiento, empleo de estos compuestos para la lucha contra las plantas indeseables, y composiciones
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
IT1307866B1 (it) Composizioni farmaceutiche contenenti inibitori dell'ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento
HUP9902191A2 (hu) Az érképződést gátló anyag
CA2345409A1 (en) Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
IT1270145B (it) Composizione farmaceutica atta a diminuire i livelli plasmatici della lipoproteina (a)
TH21056A (th) การรักษาที่ประกอบกันสำหรับการยับยั้งการสูญเสียกระดูก

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee